Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study

Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study

Cefiderocol is a novel siderophore cephalosporin, which has proven in vitro activity against carbapenem-resistant (CR) Gram-negative pathogens and stability towards all carbapenemases. The aim of this study was to describe the first cases of prescriptions and the efficacy of cefiderocol for compassi...

Full description

Bibliographic Details
Main Authors: Alexandre Bleibtreu, Laurent Dortet, Remy A. Bonnin, Benjamin Wyplosz, Sophie-Caroline Sacleux, Liliana Mihaila, Hervé Dupont, Helga Junot, Vincent Bunel, Nathalie Grall, Keyvan Razazi, Clara Duran, Pierre Tattevin, Aurélien Dinh, on behalf of the Cefiderocol French Study Group
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Microorganisms
Subjects:
cefiderocol
bacterial resistance
carbapenem
respiratory tract infection
<i>Pseudomonas aeruginosa</i>
Online Access:https://www.mdpi.com/2076-2607/9/2/282

Internet

https://www.mdpi.com/2076-2607/9/2/282

Similar Items